home / stock / clsn / clsn news

CLSN News and Press, Celsion Corporation From 04/14/22

Stock Information
Company Name: Celsion Corporation
Stock Symbol: CLSN
Market: NASDAQ
Website: celsion.com
Menu
CLSN CLSN Quote CLSN Short CLSN News CLSN Articles CLSN Message Board
Get CLSN Alerts

News, Short Squeeze, Breakout and More Instantly...
CLSN - Celsion and Medidata Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial at 2022 AACR Annual Meeting

Phase Ib dose-escalating OVATION I Study with GEN-1 in advanced ovarian cancer patients was well received at 2022 AACR A nnual M eeti ng LAWRENCEVILLE, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) a clini...
CLSN - H.C. Wainwright initiates coverage on Celsion with a buy rating on promising DNA-based COVID-19 vaccine program

Celsion Corporation (NASDAQ:CLSN +11.5%) stock jumps after H.C. Wainwright analyst Emily Bodnar initiates coverage on the stock with a Buy rating and a price target of $16, implies a 360% increase from last price. The company is developing its novel DNA-based pla...

CLSN - AAL, UAL and CLSN among pre market gainers

Antares Pharma ATRS +49% on ~$1B acquisition deal by Halozyme. Sierra Oncology SRRA +37% GSK to acquire Sierra Oncology for $1.9B to bolster specialty meds. BriaCell Therapeutics (BCTX) +17% receives FDA fast track approval for targeted breast cancer immunotherapy. Hi...

CLSN - Celsion Corporation to Highlight its PLACCINE Platform Technology During Oral Presentation at the World Vaccine Congress

LAWRENCEVILLE, N.J., April 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today announced it would highlight its PLACCINE platform technology in an oral presentation at the Wo...
CLSN - Celsion Corporation Announces Closing of $7.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

LAWRENCEVILLE, NJ, April 08, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules, of 1,328,27...

CLSN - SND, VLD and ADN among mid-day movers

Gainers: Advent Technologies (ADN) +79%. Tufin Software Technologies (TUFN) +43%. Mobiquity Technologies (OTCQB:MOBQ) +30%. Missfresh (MF) +25%. Venator Materials (VNTR) +17%. Team (TISI) +16%. Concord Medical Services (CCM) +15%. NextDecade (NEXT) +15%. Smart Sand (SND) +13%. ...

CLSN - Tilray, Clever Leaves top healthcare gainers; Celsion, IMARA lead losers' pack

Gainers: Tilray Brands (TLRY) +15%. Clever Leaves (CLVR) +12%. Ensysce Biosciences (ENSC) +11%. Icosavax (ICVX) +10%. Cullinan Oncology (CGEM) +6%. Losers: Celsion (CLSN) -19%. IMARA (IMRA) -14%. Owlet (OWLT) -12%. PAVmed (PAVM) -10%. Accelerate Diagnos...
CLSN - Celsion slides on $7 million common stock offering

Clinical-stage biotech, Celsion Corporation (NASDAQ:CLSN) has crashed ~19% in the pre-market Wednesday after announcing a direct offering of its common stock for $7.0 million gross proceeds. The company said that it reached definitive agreements with institutional investors to purch...

CLSN - Celsion and Medidata to Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial

Phase Ib dose-escalating OVATION I Study with GEN-1 in advanced ovarian cancer patients to be presented at 2022 AACR A nnual M eeti ng being held April 8-13 in New Orleans, LA LAWRENCEVILLE, N.J., April 06, 2022 (GLOBE NEWSWIRE) -- Celsion Cor...

CLSN - CELSION CORPORATION ANNOUNCES $7.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

LAWRENCEVILLE, NJ, April 06, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into definitive agreements with institutional investors for the purchase and sale of 1,328,274 shar...
Previous 10 Next 10